Ildong Pharmaceutical and Ildong Holdings Annual General Meeting... "We Will Emerge as a Global New Drug Development Company Focused on R&D"

[Asia Economy Reporter Lee Gwan-joo] Ildong Pharmaceutical and Ildong Holdings each held their regular general meetings of shareholders on the 25th at the Ildong Pharmaceutical headquarters in Seocho-gu, Seoul.

At the 6th regular general meeting of shareholders of Ildong Pharmaceutical, which was opened first, all proposed agenda items, including approval of the financial statements and appointment of directors and auditors, were approved as originally proposed.

?

Yoon Woong-seop, CEO of Ildong Pharmaceutical, said in his greeting, “To become a global new drug development company centered on R&D, we have built an environment including bold investments and the organization and process improvements of R&D,” adding, “This year as well, through continuous investment, we will not neglect enhancing future value, establishing a foundation for sustainable management, as well as sales, marketing, and quality innovation.”

?

CEO Yoon added, “We plan to focus our capabilities not only on the clinical trials and commercialization of COVID-19 therapeutics but also on new drug development projects such as diabetes treatments and non-alcoholic steatohepatitis (NASH) therapeutics to show more visible results.”

?

At the 79th regular general meeting of shareholders of the holding company Ildong Holdings, all agenda items, including approval of the financial statements and appointment of directors and auditors, were also passed as originally proposed.

?

Park Dae-chang, CEO of Ildong Holdings, emphasized, “Over the past year, we have worked to create performance and enhance corporate value of our affiliates and to establish a foundation for sustainable growth,” adding, “We will spare no cooperation and support for the management activities of our affiliates, including the R&D achievements of Ildong Pharmaceutical and the listing promotion of Ildong Bioscience.”

This content was produced with the assistance of AI translation services.